BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 29720192)

  • 1. The impact of severe haemophilia and the presence of target joints on health-related quality-of-life.
    O'Hara J; Walsh S; Camp C; Mazza G; Carroll L; Hoxer C; Wilkinson L
    Health Qual Life Outcomes; 2018 May; 16(1):84. PubMed ID: 29720192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B.
    Booth J; Oladapo A; Walsh S; O'Hara J; Carroll L; Garcia Diego DA; O'Mahony B
    Haemophilia; 2018 Sep; 24(5):e322-e327. PubMed ID: 30091822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social/economic costs and quality of life in patients with haemophilia in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between target joints and direct resource use in severe haemophilia.
    O'Hara J; Walsh S; Camp C; Mazza G; Carroll L; Hoxer C; Wilkinson L
    Health Econ Rev; 2018 Jan; 8(1):1. PubMed ID: 29340855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the impact of haemophilia treatment on health-related quality of life.
    Shaikh A; Pedra G; Cawson M; Wiseman C
    Haemophilia; 2022 Sep; 28(5):796-805. PubMed ID: 35537107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No difference in quality of life between persons with severe haemophilia A and B.
    Kihlberg K; Baghaei F; Bruzelius M; Funding E; Andre Holme P; Lassila R; Nummi V; Ranta S; Gretenkort Andersson N; Berntorp E; Astermark J
    Haemophilia; 2023 Jul; 29(4):987-996. PubMed ID: 36791275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe.
    Burke T; Asghar S; O'Hara J; Chuang M; Sawyer EK; Li N
    Orphanet J Rare Dis; 2021 Dec; 16(1):521. PubMed ID: 34930388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B.
    Burke T; Shaikh A; Ali TM; Li N; Curtis R; Garcia Diego DA; Recht M; Sannie T; Skinner M; O'Hara J
    J Med Econ; 2022; 25(1):386-392. PubMed ID: 35253589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of bleeding event frequency on health-related quality of life and work productivity outcomes in a European cohort of adults with haemophilia A: insights from the CHESS II study.
    Young L; Chen Y; Alvir J; Burke T; Ferri Grazzi E; Winburn I
    Orphanet J Rare Dis; 2023 Aug; 18(1):227. PubMed ID: 37537683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life, direct medical and societal costs among children with moderate or severe haemophilia in Europe: multivariable models of the CHESS-PAEDs study.
    Rodriguez-Santana I; DasMahapatra P; Burke T; Hakimi Z; Bartelt-Hofer J; Nazir J; O'Hara J
    Orphanet J Rare Dis; 2022 Apr; 17(1):150. PubMed ID: 35379284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of severe haemophilia in Europe: the CHESS study.
    O'Hara J; Hughes D; Camp C; Burke T; Carroll L; Diego DG
    Orphanet J Rare Dis; 2017 May; 12(1):106. PubMed ID: 28569181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Quality of Life of Patients With Hemophilia and Juvenile Idiopathic Arthritis in Which Chronic Arthropathy Is a Common Complication.
    Oymak Y; Kaygusuz A; Turedi A; Yaman Y; Eser E; Cubukcu D; Vergin C
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):600-4. PubMed ID: 26479992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of joint disease, inhibitors and other complications on health-related quality of life among males with severe haemophilia A in the United States.
    Soucie JM; Grosse SD; Siddiqi AE; Byams V; Thierry J; Zack MM; Shapiro A; Duncan N;
    Haemophilia; 2017 Jul; 23(4):e287-e293. PubMed ID: 28574229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanistic burden of problem joints for children and adults with haemophilia.
    Burke T; Rodriguez-Santana I; Chowdary P; Curtis R; Khair K; Laffan M; Mclaughlin P; Noone D; O'Mahony B; Pasi J; Skinner M; O'Hara J
    Haemophilia; 2023 Mar; 29(2):608-618. PubMed ID: 36574369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported outcomes and joint status across subgroups of US adults with hemophilia with varying characteristics: Results from the Pain, Functional Impairment, and Quality of Life (P-FiQ) study.
    Batt K; Boggio L; Neff A; Buckner TW; Wang M; Quon D; Witkop M; Recht M; Kessler C; Iyer NN; Cooper DL
    Eur J Haematol; 2018 Apr; 100 Suppl 1():14-24. PubMed ID: 29498783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia.
    Rattray B; Nugent DJ; Young G
    Haemophilia; 2006 Sep; 12(5):514-7. PubMed ID: 16919082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement properties of the Haem-A-QoL in haemophilia clinical trials.
    von Mackensen S; Eldar-Lissai A; Auguste P; Krishnan S; von Maltzahn R; Yu R; Wyrwich KW
    Haemophilia; 2017 May; 23(3):383-391. PubMed ID: 28026074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of joint range of motion limitations on health-related quality of life in patients with haemophilia A: a prospective study.
    Chen CM; Huang KC; Chen CC; Huang SU; Huang CE; Chen YY; Hsu SL
    Haemophilia; 2015 May; 21(3):e176-e184. PubMed ID: 25684270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of sport on health status, psychological well-being and physical performance of adults with haemophilia.
    von Mackensen S; Harrington C; Tuddenham E; Littley A; Will A; Fareh M; Hay CR; Khair K
    Haemophilia; 2016 Jul; 22(4):521-30. PubMed ID: 27216698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with pain severity, pain interference, and perception of functional abilities independent of joint status in US adults with hemophilia: Multivariable analysis of the Pain, Functional Impairment, and Quality of Life (P-FiQ) study.
    Kempton CL; Buckner TW; Fridman M; Iyer NN; Cooper DL
    Eur J Haematol; 2018 Apr; 100 Suppl 1():25-33. PubMed ID: 29498782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.